Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02177318
Other study ID # 205.314
Secondary ID
Status Completed
Phase N/A
First received January 31, 2008
Last updated June 26, 2014
Start date April 2005

Study information

Verified date June 2014
Source Boehringer Ingelheim
Contact n/a
Is FDA regulated No
Health authority Japan: Ministry of Health, Labor and Welfare
Study type Observational

Clinical Trial Summary

To collect post-marketing safety and effectiveness information on the use of Tiotropium Inhalation Capsules (18 μg) in patients with chronic obstructive pulmonary disease in daily clinical settings


Recruitment information / eligibility

Status Completed
Enrollment 3588
Est. completion date
Est. primary completion date September 2007
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with COPD

Exclusion Criteria:

-There is no exclusion criterion, because this post marketing study (PMS) is observational survey under condition of normal clinical practice

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Drug:
Spiriva (tiotropium bromide) inhalation capsules
Survey of patients with COPD using Spiriva (tiotropium bromide) inhalation capsules

Locations

Country Name City State
Japan Boehringer Ingelheim Investigational Site Abashiri
Japan Boehringer Ingelheim Investigational Site Aizubangemachi
Japan Boehringer Ingelheim Investigational Site Aizumisatomachi
Japan Boehringer Ingelheim Investigational Site Aizuwakamatsu
Japan Boehringer Ingelheim Investigational Site Akashi
Japan Boehringer Ingelheim Investigational Site Akita
Japan Boehringer Ingelheim Investigational Site Ako
Japan Boehringer Ingelheim Investigational Site Amagasaki
Japan Boehringer Ingelheim Investigational Site Amakusa
Japan Boehringer Ingelheim Investigational Site Amimachi
Japan Boehringer Ingelheim Investigational Site Anan
Japan Boehringer Ingelheim Investigational Site Anjo
Japan Boehringer Ingelheim Investigational Site Arakawamachi
Japan Boehringer Ingelheim Investigational Site Arao
Japan Boehringer Ingelheim Investigational Site Aritacho
Japan Boehringer Ingelheim Investigational Site Asahikawa
Japan Boehringer Ingelheim Investigational Site Ashikaga
Japan Boehringer Ingelheim Investigational Site Atami
Japan Boehringer Ingelheim Investigational Site Atsugi
Japan Boehringer Ingelheim Investigational Site Awa
Japan Boehringer Ingelheim Investigational Site Ayabe
Japan Boehringer Ingelheim Investigational Site Ayagawacho
Japan Boehringer Ingelheim Investigational Site Ayase
Japan Boehringer Ingelheim Investigational Site Beppu
Japan Boehringer Ingelheim Investigational Site Bibai
Japan Boehringer Ingelheim Investigational Site Bungoohno
Japan Boehringer Ingelheim Investigational Site Chiba
Japan Boehringer Ingelheim Investigational Site Chigasaki
Japan Boehringer Ingelheim Investigational Site Chikusei
Japan Boehringer Ingelheim Investigational Site Chikushino
Japan Boehringer Ingelheim Investigational Site Chitose
Japan Boehringer Ingelheim Investigational Site Date
Japan Boehringer Ingelheim Investigational Site Ebetsu
Japan Boehringer Ingelheim Investigational Site Echizen
Japan Boehringer Ingelheim Investigational Site Emukaecho
Japan Boehringer Ingelheim Investigational Site Engarucho
Japan Boehringer Ingelheim Investigational Site Fuchuu
Japan Boehringer Ingelheim Investigational Site Fuji
Japan Boehringer Ingelheim Investigational Site Fujiidera
Japan Boehringer Ingelheim Investigational Site Fujikawaguchiko
Japan Boehringer Ingelheim Investigational Site Fujinomiya
Japan Boehringer Ingelheim Investigational Site Fukagawa
Japan Boehringer Ingelheim Investigational Site Fukaya
Japan Boehringer Ingelheim Investigational Site Fukuchiyama
Japan Boehringer Ingelheim Investigational Site Fukui
Japan Boehringer Ingelheim Investigational Site Fukuoka
Japan Boehringer Ingelheim Investigational Site Fukuroi
Japan Boehringer Ingelheim Investigational Site Fukushima
Japan Boehringer Ingelheim Investigational Site Fukutsu
Japan Boehringer Ingelheim Investigational Site Fukuyama
Japan Boehringer Ingelheim Investigational Site Funabashi
Japan Boehringer Ingelheim Investigational Site Futabamachi
Japan Boehringer Ingelheim Investigational Site Geiseimura
Japan Boehringer Ingelheim Investigational Site Gifu
Japan Boehringer Ingelheim Investigational Site Ginowan
Japan Boehringer Ingelheim Investigational Site Gobo
Japan Boehringer Ingelheim Investigational Site Gosen
Japan Boehringer Ingelheim Investigational Site Gotenba
Japan Boehringer Ingelheim Investigational Site Gyouda
Japan Boehringer Ingelheim Investigational Site Habikino
Japan Boehringer Ingelheim Investigational Site Hachinohe
Japan Boehringer Ingelheim Investigational Site Hachirogatamachi
Japan Boehringer Ingelheim Investigational Site Hagi
Japan Boehringer Ingelheim Investigational Site Hakodate
Japan Boehringer Ingelheim Investigational Site Hakusan
Japan Boehringer Ingelheim Investigational Site Hamada
Japan Boehringer Ingelheim Investigational Site Hamamatsu
Japan Boehringer Ingelheim Investigational Site Handa
Japan Boehringer Ingelheim Investigational Site Hanyuu
Japan Boehringer Ingelheim Investigational Site Hatsukaichi
Japan Boehringer Ingelheim Investigational Site Hayashimacho
Japan Boehringer Ingelheim Investigational Site Higashihiroshima
Japan Boehringer Ingelheim Investigational Site Higashimatsushima
Japan Boehringer Ingelheim Investigational Site Higashiomi
Japan Boehringer Ingelheim Investigational Site Higashiosaka
Japan Boehringer Ingelheim Investigational Site Hikari
Japan Boehringer Ingelheim Investigational Site Himeji
Japan Boehringer Ingelheim Investigational Site Hirakata
Japan Boehringer Ingelheim Investigational Site Hiratsuka
Japan Boehringer Ingelheim Investigational Site Hirosaki
Japan Boehringer Ingelheim Investigational Site Hiroshima
Japan Boehringer Ingelheim Investigational Site Hita
Japan Boehringer Ingelheim Investigational Site Hitachi
Japan Boehringer Ingelheim Investigational Site Hitoyoshi
Japan Boehringer Ingelheim Investigational Site Hofu
Japan Boehringer Ingelheim Investigational Site Iamabari
Japan Boehringer Ingelheim Investigational Site Ibaraki
Japan Boehringer Ingelheim Investigational Site Ibarakimachi
Japan Boehringer Ingelheim Investigational Site Ibigawacho
Japan Boehringer Ingelheim Investigational Site Ibusuki
Japan Boehringer Ingelheim Investigational Site Ichihara
Japan Boehringer Ingelheim Investigational Site Ichinomiya
Japan Boehringer Ingelheim Investigational Site Ichinoseki
Japan Boehringer Ingelheim Investigational Site Iga
Japan Boehringer Ingelheim Investigational Site Iida
Japan Boehringer Ingelheim Investigational Site Iizuka
Japan Boehringer Ingelheim Investigational Site Ikoma
Japan Boehringer Ingelheim Investigational Site Imari
Japan Boehringer Ingelheim Investigational Site Imizu
Japan Boehringer Ingelheim Investigational Site Ina
Japan Boehringer Ingelheim Investigational Site Inazawa
Japan Boehringer Ingelheim Investigational Site Inuyama
Japan Boehringer Ingelheim Investigational Site Isahaya
Japan Boehringer Ingelheim Investigational Site Ise
Japan Boehringer Ingelheim Investigational Site Isehara
Japan Boehringer Ingelheim Investigational Site Ishikari
Japan Boehringer Ingelheim Investigational Site Ishinomaki
Japan Boehringer Ingelheim Investigational Site Itami
Japan Boehringer Ingelheim Investigational Site Itanocho
Japan Boehringer Ingelheim Investigational Site Ito
Japan Boehringer Ingelheim Investigational Site Iwaki
Japan Boehringer Ingelheim Investigational Site Iwakuni
Japan Boehringer Ingelheim Investigational Site Iwamizawa
Japan Boehringer Ingelheim Investigational Site Iwanaicho
Japan Boehringer Ingelheim Investigational Site Iwata
Japan Boehringer Ingelheim Investigational Site Iyo
Japan Boehringer Ingelheim Investigational Site Izu
Japan Boehringer Ingelheim Investigational Site Izumisano
Japan Boehringer Ingelheim Investigational Site Izumo
Japan Boehringer Ingelheim Investigational Site Izunokuni
Japan Boehringer Ingelheim Investigational Site Jimokujicho
Japan Boehringer Ingelheim Investigational Site Joso
Japan Boehringer Ingelheim Investigational Site Jouetsu
Japan Boehringer Ingelheim Investigational Site Joyo
Japan Boehringer Ingelheim Investigational Site Kaga
Japan Boehringer Ingelheim Investigational Site Kagoshima
Japan Boehringer Ingelheim Investigational Site Kaizuka
Japan Boehringer Ingelheim Investigational Site Kajikicho
Japan Boehringer Ingelheim Investigational Site Kakegawa
Japan Boehringer Ingelheim Investigational Site Kami
Japan Boehringer Ingelheim Investigational Site Kamiamakusa
Japan Boehringer Ingelheim Investigational Site Kamisu
Japan Boehringer Ingelheim Investigational Site Kanazawa
Japan Boehringer Ingelheim Investigational Site Kandamachi
Japan Boehringer Ingelheim Investigational Site Kanonji
Japan Boehringer Ingelheim Investigational Site Kasai
Japan Boehringer Ingelheim Investigational Site Kasama
Japan Boehringer Ingelheim Investigational Site Kasaoka
Japan Boehringer Ingelheim Investigational Site Kashihara
Japan Boehringer Ingelheim Investigational Site Kashima
Japan Boehringer Ingelheim Investigational Site Kashiwazaki
Japan Boehringer Ingelheim Investigational Site Kasuga
Japan Boehringer Ingelheim Investigational Site Kasuigai
Japan Boehringer Ingelheim Investigational Site Kasukabe
Japan Boehringer Ingelheim Investigational Site Kasuyamachi
Japan Boehringer Ingelheim Investigational Site Kato
Japan Boehringer Ingelheim Investigational Site Katsuyama
Japan Boehringer Ingelheim Investigational Site Kawachinagano
Japan Boehringer Ingelheim Investigational Site Kawagoe
Japan Boehringer Ingelheim Investigational Site Kawaguchi
Japan Boehringer Ingelheim Investigational Site Kawanishimachi
Japan Boehringer Ingelheim Investigational Site Kawasaki
Japan Boehringer Ingelheim Investigational Site Kayano
Japan Boehringer Ingelheim Investigational Site Kazuno
Japan Boehringer Ingelheim Investigational Site Kinkocho
Japan Boehringer Ingelheim Investigational Site Kitakami
Japan Boehringer Ingelheim Investigational Site Kitakyushu
Japan Boehringer Ingelheim Investigational Site Kitami
Japan Boehringer Ingelheim Investigational Site Kobe
Japan Boehringer Ingelheim Investigational Site Kochi
Japan Boehringer Ingelheim Investigational Site Koga
Japan Boehringer Ingelheim Investigational Site Komonocho
Japan Boehringer Ingelheim Investigational Site Konan
Japan Boehringer Ingelheim Investigational Site Koriyama
Japan Boehringer Ingelheim Investigational Site Kouriyama
Japan Boehringer Ingelheim Investigational Site Koushi
Japan Boehringer Ingelheim Investigational Site Koushu
Japan Boehringer Ingelheim Investigational Site Kozakaicho
Japan Boehringer Ingelheim Investigational Site Kudamatsu
Japan Boehringer Ingelheim Investigational Site Kumamoto
Japan Boehringer Ingelheim Investigational Site Kunimimachi
Japan Boehringer Ingelheim Investigational Site Kunisaki
Japan Boehringer Ingelheim Investigational Site Kurashiki
Japan Boehringer Ingelheim Investigational Site Kurayoshi
Japan Boehringer Ingelheim Investigational Site Kure
Japan Boehringer Ingelheim Investigational Site Kurihara
Japan Boehringer Ingelheim Investigational Site Kurume
Japan Boehringer Ingelheim Investigational Site Kushiro
Japan Boehringer Ingelheim Investigational Site Kuwana
Japan Boehringer Ingelheim Investigational Site Kyotango
Japan Boehringer Ingelheim Investigational Site Kyoto
Japan Boehringer Ingelheim Investigational Site Maebashi
Japan Boehringer Ingelheim Investigational Site Marugame
Japan Boehringer Ingelheim Investigational Site Masuda
Japan Boehringer Ingelheim Investigational Site Matsudo
Japan Boehringer Ingelheim Investigational Site Matsue
Japan Boehringer Ingelheim Investigational Site Matsumoto
Japan Boehringer Ingelheim Investigational Site Matsusaka
Japan Boehringer Ingelheim Investigational Site Matsuyama
Japan Boehringer Ingelheim Investigational Site Mibumachi
Japan Boehringer Ingelheim Investigational Site Mihamacho
Japan Boehringer Ingelheim Investigational Site Mihara
Japan Boehringer Ingelheim Investigational Site Minamisatsuma
Japan Boehringer Ingelheim Investigational Site Minamisouma
Japan Boehringer Ingelheim Investigational Site Minamiuonuma
Japan Boehringer Ingelheim Investigational Site Mino
Japan Boehringer Ingelheim Investigational Site Minoh
Japan Boehringer Ingelheim Investigational Site Misasacho
Japan Boehringer Ingelheim Investigational Site Misato
Japan Boehringer Ingelheim Investigational Site Mishima
Japan Boehringer Ingelheim Investigational Site Mito
Japan Boehringer Ingelheim Investigational Site Miyakicho
Japan Boehringer Ingelheim Investigational Site Miyakonojo
Japan Boehringer Ingelheim Investigational Site Miyazaki
Japan Boehringer Ingelheim Investigational Site Miyoshi
Japan Boehringer Ingelheim Investigational Site Mizunami
Japan Boehringer Ingelheim Investigational Site Mobara
Japan Boehringer Ingelheim Investigational Site Moriguchi
Japan Boehringer Ingelheim Investigational Site Morioka
Japan Boehringer Ingelheim Investigational Site Muroran
Japan Boehringer Ingelheim Investigational Site Nabari
Japan Boehringer Ingelheim Investigational Site Nagahama
Japan Boehringer Ingelheim Investigational Site Nagano
Japan Boehringer Ingelheim Investigational Site Nagaoka
Japan Boehringer Ingelheim Investigational Site Nagasaki
Japan Boehringer Ingelheim Investigational Site Nagato
Japan Boehringer Ingelheim Investigational Site Nago
Japan Boehringer Ingelheim Investigational Site Nagoya
Japan Boehringer Ingelheim Investigational Site Naha
Japan Boehringer Ingelheim Investigational Site Nakama
Japan Boehringer Ingelheim Investigational Site Nakashibetsucho
Japan Boehringer Ingelheim Investigational Site Nanao
Japan Boehringer Ingelheim Investigational Site Nankoku
Japan Boehringer Ingelheim Investigational Site Nantan
Japan Boehringer Ingelheim Investigational Site Nara
Japan Boehringer Ingelheim Investigational Site Naruto
Japan Boehringer Ingelheim Investigational Site Nasukarasuyama
Japan Boehringer Ingelheim Investigational Site Neyagawa
Japan Boehringer Ingelheim Investigational Site Nihonmatsu
Japan Boehringer Ingelheim Investigational Site Niigata
Japan Boehringer Ingelheim Investigational Site Niihamashi
Japan Boehringer Ingelheim Investigational Site Nikko
Japan Boehringer Ingelheim Investigational Site Nishiiyo
Japan Boehringer Ingelheim Investigational Site Nishinomiya
Japan Boehringer Ingelheim Investigational Site Nishio
Japan Boehringer Ingelheim Investigational Site Nobeoka
Japan Boehringer Ingelheim Investigational Site Noboribetsu
Japan Boehringer Ingelheim Investigational Site Noda
Japan Boehringer Ingelheim Investigational Site Nomi
Japan Boehringer Ingelheim Investigational Site Noshiro
Japan Boehringer Ingelheim Investigational Site Notocho
Japan Boehringer Ingelheim Investigational Site Numata
Japan Boehringer Ingelheim Investigational Site Numazu
Japan Boehringer Ingelheim Investigational Site Oaraimachi
Japan Boehringer Ingelheim Investigational Site Obama
Japan Boehringer Ingelheim Investigational Site Obihiro
Japan Boehringer Ingelheim Investigational Site Odate
Japan Boehringer Ingelheim Investigational Site Odawara
Japan Boehringer Ingelheim Investigational Site Ogawaramachi
Japan Boehringer Ingelheim Investigational Site Ogi
Japan Boehringer Ingelheim Investigational Site Oita
Japan Boehringer Ingelheim Investigational Site Ojiya
Japan Boehringer Ingelheim Investigational Site Okayama
Japan Boehringer Ingelheim Investigational Site Okinawa
Japan Boehringer Ingelheim Investigational Site Omihachiman
Japan Boehringer Ingelheim Investigational Site Omuta
Japan Boehringer Ingelheim Investigational Site Onomachi
Japan Boehringer Ingelheim Investigational Site Osaka
Japan Boehringer Ingelheim Investigational Site Osakasayama
Japan Boehringer Ingelheim Investigational Site Ota
Japan Boehringer Ingelheim Investigational Site Otake
Japan Boehringer Ingelheim Investigational Site Otaru
Japan Boehringer Ingelheim Investigational Site Otsu
Japan Boehringer Ingelheim Investigational Site Otsumachi
Japan Boehringer Ingelheim Investigational Site Owariasahi
Japan Boehringer Ingelheim Investigational Site Ritto
Japan Boehringer Ingelheim Investigational Site Ryugasaki
Japan Boehringer Ingelheim Investigational Site Sado
Japan Boehringer Ingelheim Investigational Site Saga
Japan Boehringer Ingelheim Investigational Site Sagamihara
Japan Boehringer Ingelheim Investigational Site Saiki
Japan Boehringer Ingelheim Investigational Site Saitama
Japan Boehringer Ingelheim Investigational Site Sakacho
Japan Boehringer Ingelheim Investigational Site Sakai
Japan Boehringer Ingelheim Investigational Site Sakaimachi
Japan Boehringer Ingelheim Investigational Site Sakaiminato
Japan Boehringer Ingelheim Investigational Site Sakata
Japan Boehringer Ingelheim Investigational Site Saku
Japan Boehringer Ingelheim Investigational Site Sanjyo
Japan Boehringer Ingelheim Investigational Site Sanuki
Japan Boehringer Ingelheim Investigational Site Sanyoonoda
Japan Boehringer Ingelheim Investigational Site Sapporo
Japan Boehringer Ingelheim Investigational Site Sasayama
Japan Boehringer Ingelheim Investigational Site Sasebo
Japan Boehringer Ingelheim Investigational Site Satsumasendai
Japan Boehringer Ingelheim Investigational Site Sayama
Japan Boehringer Ingelheim Investigational Site Sendai
Japan Boehringer Ingelheim Investigational Site Sennan
Japan Boehringer Ingelheim Investigational Site Shibetsu
Japan Boehringer Ingelheim Investigational Site Shibukawa
Japan Boehringer Ingelheim Investigational Site Shimada
Japan Boehringer Ingelheim Investigational Site Shimonoseki
Japan Boehringer Ingelheim Investigational Site Shimotsuke
Japan Boehringer Ingelheim Investigational Site Shimotsuma
Japan Boehringer Ingelheim Investigational Site Shingu
Japan Boehringer Ingelheim Investigational Site Shiogama
Japan Boehringer Ingelheim Investigational Site Shirahamacho
Japan Boehringer Ingelheim Investigational Site Shiroishi
Japan Boehringer Ingelheim Investigational Site Shiroishicho
Japan Boehringer Ingelheim Investigational Site Shizuoka
Japan Boehringer Ingelheim Investigational Site Shoocho
Japan Boehringer Ingelheim Investigational Site Shunan
Japan Boehringer Ingelheim Investigational Site Soo
Japan Boehringer Ingelheim Investigational Site Souka
Japan Boehringer Ingelheim Investigational Site Suita
Japan Boehringer Ingelheim Investigational Site Sukagawa
Japan Boehringer Ingelheim Investigational Site Sukumo
Japan Boehringer Ingelheim Investigational Site Sunagawa
Japan Boehringer Ingelheim Investigational Site Susono
Japan Boehringer Ingelheim Investigational Site Suwa
Japan Boehringer Ingelheim Investigational Site Suzuka
Japan Boehringer Ingelheim Investigational Site Tagawa
Japan Boehringer Ingelheim Investigational Site Tainai
Japan Boehringer Ingelheim Investigational Site Takahashi
Japan Boehringer Ingelheim Investigational Site Takamatsu
Japan Boehringer Ingelheim Investigational Site Takaoka
Japan Boehringer Ingelheim Investigational Site Takarazuka
Japan Boehringer Ingelheim Investigational Site Takasago
Japan Boehringer Ingelheim Investigational Site Takashima
Japan Boehringer Ingelheim Investigational Site Takatsuki
Japan Boehringer Ingelheim Investigational Site Taku
Japan Boehringer Ingelheim Investigational Site Tamana
Japan Boehringer Ingelheim Investigational Site Tamano
Japan Boehringer Ingelheim Investigational Site Tanabe
Japan Boehringer Ingelheim Investigational Site Taragimachi
Japan Boehringer Ingelheim Investigational Site Tenri
Japan Boehringer Ingelheim Investigational Site Tokaimura
Japan Boehringer Ingelheim Investigational Site Tokamachi
Japan Boehringer Ingelheim Investigational Site Tokorozawa
Japan Boehringer Ingelheim Investigational Site Tokunoshimacho
Japan Boehringer Ingelheim Investigational Site Tokushima
Japan Boehringer Ingelheim Investigational Site Tokyo Adachi-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Akishima
Japan Boehringer Ingelheim Investigational Site Tokyo Bunkyo-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Chiyoda-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Edogawa-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Hachioji
Japan Boehringer Ingelheim Investigational Site Tokyo Higashimurayama
Japan Boehringer Ingelheim Investigational Site Tokyo Higashiyamato
Japan Boehringer Ingelheim Investigational Site Tokyo Hino
Japan Boehringer Ingelheim Investigational Site Tokyo Itabashi-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Katsushika-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Kiyose
Japan Boehringer Ingelheim Investigational Site Tokyo Komae
Japan Boehringer Ingelheim Investigational Site Tokyo Koto-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Meguro-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Minato-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Nakano-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Nerima-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Nishitokyo
Japan Boehringer Ingelheim Investigational Site Tokyo Ome
Japan Boehringer Ingelheim Investigational Site Tokyo Ota-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Setagaya-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Shibuya-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Shinagawa-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Shinjuku-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Suginami-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Sumida-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Taito-ku
Japan Boehringer Ingelheim Investigational Site Tokyo Toshima-ku
Japan Boehringer Ingelheim Investigational Site Tomakomai
Japan Boehringer Ingelheim Investigational Site Tomigusu
Japan Boehringer Ingelheim Investigational Site Tomioka
Japan Boehringer Ingelheim Investigational Site Tondabayashi
Japan Boehringer Ingelheim Investigational Site Toride
Japan Boehringer Ingelheim Investigational Site Tottori
Japan Boehringer Ingelheim Investigational Site Toyama
Japan Boehringer Ingelheim Investigational Site Toyohashi
Japan Boehringer Ingelheim Investigational Site Toyokawa
Japan Boehringer Ingelheim Investigational Site Toyooka
Japan Boehringer Ingelheim Investigational Site Toyosatocho
Japan Boehringer Ingelheim Investigational Site Toyota
Japan Boehringer Ingelheim Investigational Site Tsu
Japan Boehringer Ingelheim Investigational Site Tsukuba
Japan Boehringer Ingelheim Investigational Site Tsurugicho
Japan Boehringer Ingelheim Investigational Site Tsuruoka
Japan Boehringer Ingelheim Investigational Site Tsushima
Japan Boehringer Ingelheim Investigational Site Tsuyama
Japan Boehringer Ingelheim Investigational Site Ube
Japan Boehringer Ingelheim Investigational Site Uchikocho
Japan Boehringer Ingelheim Investigational Site Uchinadamachi
Japan Boehringer Ingelheim Investigational Site Uekimachi
Japan Boehringer Ingelheim Investigational Site Uji
Japan Boehringer Ingelheim Investigational Site Uki
Japan Boehringer Ingelheim Investigational Site Unzen
Japan Boehringer Ingelheim Investigational Site Urakawacho
Japan Boehringer Ingelheim Investigational Site Urasoe
Japan Boehringer Ingelheim Investigational Site Urayasu
Japan Boehringer Ingelheim Investigational Site Uruma
Japan Boehringer Ingelheim Investigational Site Usa
Japan Boehringer Ingelheim Investigational Site Usuki
Japan Boehringer Ingelheim Investigational Site Utsunomiya
Japan Boehringer Ingelheim Investigational Site Wakayama
Japan Boehringer Ingelheim Investigational Site Yabu
Japan Boehringer Ingelheim Investigational Site Yachimata
Japan Boehringer Ingelheim Investigational Site Yachiyo
Japan Boehringer Ingelheim Investigational Site Yaizu
Japan Boehringer Ingelheim Investigational Site Yakumocho
Japan Boehringer Ingelheim Investigational Site Yakushimacho
Japan Boehringer Ingelheim Investigational Site Yamaga
Japan Boehringer Ingelheim Investigational Site Yamagata
Japan Boehringer Ingelheim Investigational Site Yamato
Japan Boehringer Ingelheim Investigational Site Yamatotakada
Japan Boehringer Ingelheim Investigational Site Yanai
Japan Boehringer Ingelheim Investigational Site Yao
Japan Boehringer Ingelheim Investigational Site Yatomi
Japan Boehringer Ingelheim Investigational Site Yatsushiro
Japan Boehringer Ingelheim Investigational Site Yawata
Japan Boehringer Ingelheim Investigational Site Yokkaichi
Japan Boehringer Ingelheim Investigational Site Yokohama
Japan Boehringer Ingelheim Investigational Site Yokosuka
Japan Boehringer Ingelheim Investigational Site Yokote
Japan Boehringer Ingelheim Investigational Site Yonabarucho
Japan Boehringer Ingelheim Investigational Site Yonezawa
Japan Boehringer Ingelheim Investigational Site Yorocho
Japan Boehringer Ingelheim Investigational Site Yoshinocho
Japan Boehringer Ingelheim Investigational Site Yufu
Japan Boehringer Ingelheim Investigational Site Yurihonjou

Sponsors (1)

Lead Sponsor Collaborator
Boehringer Ingelheim

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with adverse events Up to 4 weeks after start of treatment No
Primary Number of patients with adverse drug reactions Up to 4 weeks after start of treatment No
Primary Number of patients with serious adverse events Up to 4 weeks after start of treatment No
Secondary Physician's overall judgement by medical interview into four grades: 1. Improved 2. No Change 3. Aggravated 4.Unassessable Up to 4 weeks after start of treatment No
See also
  Status Clinical Trial Phase
Completed NCT05043428 - The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD N/A
Completed NCT00528996 - An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. Phase 2
Completed NCT03740373 - A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate Phase 1
Completed NCT05393245 - Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
Completed NCT05402020 - Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
Completed NCT04011735 - Re-usable Respimat® Soft MistTM Inhaler Study
Enrolling by invitation NCT03075709 - The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
Completed NCT03764163 - Image and Model Based Analysis of Lung Disease Early Phase 1
Completed NCT00515268 - Endotoxin Challenge Study For Healthy Men and Women Phase 1
Completed NCT04085302 - TARA Working Prototype Engagement Evaluation: Feasibility Study N/A
Completed NCT03691324 - Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study N/A
Completed NCT02236611 - A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT00153075 - Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT01009463 - A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01017952 - A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT04882124 - Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD Phase 2
Completed NCT02853123 - Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients Phase 4
Completed NCT02619357 - Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma Phase 1
Recruiting NCT05858463 - High Intensity Interval Training and Muscle Adaptations During PR N/A
Not yet recruiting NCT05032898 - Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II